Whitehead Connects presents Mike Bonney

MB-(360-dpi)-May-2014Mike Bonney

CEO of  Cubist Pharmaceuticals

“Battling Superbugs:  The Intersection of Policy and Science”

October 6, 2014
5:30 pm presentation; 6:30 pm networking reception
Whitehead Institute
Nine Cambridge Center, Cambridge, MA 02142

RSVP Now →

About Michael Bonney

Michael W. Bonney has served as CEO and member of the Board of Directors at Cubist Pharmaceuticals since June 2003. From 2003 to 2012, Mr. Bonney served as President and Chief Executive Officer. From January 2002 to June 2003, he served as President and Chief Operating Officer. From 1995 to 2001, he held various positions of increasing responsibility at Biogen, Inc., a biopharmaceutical company, including Vice President, Sales and Marketing from 1999 to 2001. While at Biogen, Mr. Bonney built the commercial infrastructure for the launch of Avonex. Prior to that, Mr. Bonney held various positions of increasing responsibility in sales, marketing and strategic planning at Zeneca Pharmaceuticals, ending his eleven-year career there serving as National Business Director.

Mr. Bonney received a B.A. in Economics from Bates College. Mr. Bonney is a Director of NPS Pharmaceuticals, Inc., a biopharmaceutical company; a Board Member of the Pharmaceutical Research and Manufacturers of America (PhRMA); a Trustee of H&Q Healthcare Investors and H&Q Life Sciences Investors Funds, and Chairman of the Board of Trustees of Bates College. Mike is a former board member of the Biotechnology Industry Organization, or BIO, Health Section Governing Body.

About Whitehead Connects

Whitehead Connects is a new initiative that brings renowned biology and biotech leaders to Whitehead Institute to share lessons learned from careers at the nexus of academic science and industry.  Join us for a free, public lecture on October 6 – the first in our 2014-2015 series.  Following the lecture, participants will have the opportunity to meet Whitehead postdoctoral fellows and learn about their latest discoveries.

Upcoming Whitehead Connects Events

December 4, 2014: Doug Fambrough, CEO, Dicerna Pharmaceuticals

March 12, 2015: Daphne Zohar, Founder and Managing Partner, PureTech Ventures